Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06192927 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of TenoMiR in Lateral Epicondylitis
A Phase 2 study of Tennis Elbow, sponsored by Causeway Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 123
- Enrollment target
- 9
- Study locations
NCT06192927: Completed Phase 2 study of Tennis Elbow, sponsored by Causeway Therapeutics.
NCT06192927 is a Phase 2 study of Tennis Elbow that has completed, run by Causeway Therapeutics. The registered enrollment target is 123 participants, above the 96-participant average among 3 other Tennis Elbow trials with a reported enrollment target (28% higher). The trial reports 9 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06192927, a Phase 2 study of Tennis Elbow, has completed, sponsored by Causeway Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 123 participants
- Enrollment target
- 9
- Study locations
Study Summary
This study is testing a drug called TenoMiR that is being developed for the treatment of tennis elbow (lateral epicondylitis). The study drug is a new compound that works by improving the quality of the collagen which helps repair damage to the elbow. The study drug is being developed in the hope of providing a more reliable treatment than those currently available and can be given at the time of first diagnosis, so that recovery can begin as soon as possible. The study drug has been tested in humans in an earlier study, and appeared to be safe and well-tolerated. This study aims to test the study drug in a larger number of participants.
Primary Outcome
Changes in pain score per group
Conditions Studied
Interventions
- DRUG 0.9% Sodium Chloride Injection
- DRUG TenoMiR
Study Locations (9)
Other
- Panthera Biopartners - Enfield
- Panthera Biopartners - Glasgow
- Glasgow Clinical Research Facility - Glasgow
- Panthera Biopartners - Preston
- Panthera Biopartners - Rochdale
- Panthera Biopartners - Sheffield
New York
- Hospital for Special Surgery - New York
- NYU Langone Health - New York
California
- Stanford Medicine - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2024-04-10 |
| Est. Completion | 2025-06-12 |
| Phase | Phase 2 |
What the finished NCT06192927 record still lists
NCT06192927 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, above the 96-participant average among 3 other Tennis Elbow trials with a reported enrollment target (28% higher).
The record links to 1 condition, with Tennis Elbow appearing as the primary indexed condition, and to 2 interventions - of which 0.9% Sodium Chloride Injection is the first listed.
NCT06192927 lists 9 locations in 3 states (Other, New York, California).
Frequently Asked Questions
What is clinical trial NCT06192927 about?
NCT06192927 is a clinical study titled "Efficacy and Safety of TenoMiR in Lateral Epicondylitis". This study is testing a drug called TenoMiR that is being developed for the treatment of tennis elbow (lateral epicondylitis). The study drug is a new compound that works by improving the quality of the collagen which helps repair damage to the elbow. The study drug is being developed in the hope of...
What is the current status of trial NCT06192927?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 123 participants. The study started on 2024-04-10. Estimated completion is 2025-06-12.
What conditions does trial NCT06192927 study?
This clinical trial studies the following conditions: Tennis Elbow.
What interventions are being tested in trial NCT06192927?
The interventions under investigation include: 0.9% Sodium Chloride Injection (DRUG), TenoMiR (DRUG).
Who is sponsoring clinical trial NCT06192927?
This trial is sponsored by Causeway Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06192927 being conducted?
This trial has 9 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tennis Elbow
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI